Piotr Iwanowski, Dr.
National Board Member of Polish Association for Good Clinical Practice (GCPpl), Warsaw, Poland; Associate Vice President Clinical Research Europe at Wockhardt Bio AG, Zug, Switzerland
Piotr Iwanowski joined pharma industry back in 1999, starting his career as a monitor of clinical studies in Baltic countries (Servier) and continuing as a clinical quality assurance manager and international GCP auditor of industry-sponsored trials. Back in management of clinical operations in Poland, he then joined Bristol-Myers Squibb to manage operations within Central & Eastern Europe and Turkey region. Since 2012 he is in charge of European clinical research conducted by Wockhardt, focusing mostly on clinical development of novel compounds, from scientific, operational as well as regulatory angles. Within his pro bono activities in Poland, as a board member, and vice-president in the past, of Polish Association for Good Clinical Practice, he contributes for more than the last decade to a variety of activities around promotion of good clinical practice, regulatory lobbying, as well as cooperation with ethics committees. He has given a number of lectures on clinical research at several Polish universities and is co-author of the most renowned national handbook of clinical research and operations “Clinical Trials”.
Piotr Iwanowski was born in Poland and is a medical doctor (educated at Medical University of Bialystok, Poland and University of Freiburg, Germany) with a postgraduate diploma in medical law and bioethics (University of Warsaw, Poland) and PhD in clinical genetics.